Table 4. Pelvic floor muscle strength in prostate cancer patients treated with radiotherapy in RePCa: a randomised controlled rehabilitation study.
Pelvic floor muscle strength |
Intervention group,
n=79 |
Control group,
n=82 |
|
|||
---|---|---|---|---|---|---|
Mean (95%CI) | Study population pre-radiation | Pre-intervention | Post intervention | Pre-intervention | Post intervention | P-valuea |
No. of participants |
n=156 |
n=73 |
n=68 |
n=75 |
n=71 |
|
Digital evaluationb |
4.0 (3.8;4.1) |
3.8 (3.5;4.0) |
3.9 (3.6;4.1) |
3.8 (3.6;4.1) |
3.7 (3.5;4.0) |
NS |
Static strength no. of seconds to hold one contraction |
34.4 (31.1;37.7) |
35.2 (30.2;40.2) |
36.1 (31.0;41.2) |
31.6 (26.6;36.6) |
32.9 (28.0;37.8) |
NS |
Dynamic strength no. of contractions during 60 s |
22.2 (19.9;24.5) |
21.2 (17.7;24.7) |
22.7 (18.9;26.5) |
19.1 (15.9;22.3) |
19.2 (15.9;22.6) |
NS |
No. of participants |
n=156 |
n=72 |
n=66 |
n=71 |
n=71 |
|
EMG average activity (μV) |
38.2 (34.8;41.6) |
31.3 (27.9;34.8) |
24.7 (21.7;27.7) |
31.6 (27.3;35.9) |
23.3 (20.4;26.2) |
NS |
EMG average rest (μV) | 6.8 (6.2;7.5) | 5.8 (5.0;6.6) | 4.8 (4.0;5.5) | 5.5 (4.9;6.1) | 4.9 (3.6;6.2) | NS |
Abbreviations: CI=class interval; EMG=electromyography.
Post-intervention differences between groups. Wilcoxon Sign-rank test. Reported P-values are two-sided and P<0.05 was considered statistically significant.
Measured by Modified Oxford Scale 0–6.